Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Nov
1
2021
New York DOL Issues FAQs on Recreational Cannabis – Guidance for Employers Epstein Becker & Green, P.C.
Jul
1
2019
Nevada Becomes First State to Prohibit Rejection of Applicants Testing Positive for Marijuana Epstein Becker & Green, P.C.
May
7
2015
CMS Amends Medicare Part D Program Integrity Regulations to Facilitate Beneficiary Access and Expand Coverage for Pharmacist Prescribers Epstein Becker & Green, P.C.
May
23
2023
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
Mar
19
2020
Families First Coronavirus Response Act: Guidance for Health Care Providers and Plans Regarding COVID-19 Epstein Becker & Green, P.C.
Nov
18
2016
Chicago Imposes Burdensome New Licensure and Disclosure Obligations on Pharmaceutical Representatives Epstein Becker & Green, P.C.
Jan
20
2017
FDA Says Yes to Pre-Approval Communications with Payors but Reaffirms its Approach to Restrictions on Off-Label Communications Epstein Becker & Green, P.C.
Feb
7
2024
NJ Approves Cannabis Regulatory Amendment with Major Impacts on Class 5 Retail License Holders Epstein Becker & Green, P.C.
Feb
2
2017
FDA Adopts New Designation Process for Regenerative Advanced Therapies Epstein Becker & Green, P.C.
Mar
26
2024
Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing Epstein Becker & Green, P.C.
Apr
11
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements Epstein Becker & Green, P.C.
Dec
17
2020
EEOC Updates COVID-19 Guidance on Employer Administered or Mandated Vaccinations Epstein Becker & Green, P.C.
Feb
8
2018
Letter from U.S. Senators Applies Additional Pressure to DEA to Promulgate “Special Registration” Rules Under the Ryan Haight Act Epstein Becker & Green, P.C.
Apr
20
2018
DEA Proposed Rule Would Limit Drug Manufacturer’s Annual Opioid Production Epstein Becker & Green, P.C.
Dec
11
2018
FDA to Overhaul Medical Device Approval Process Epstein Becker & Green, P.C.
Jan
22
2019
Not Business as Usual: The Government Shutdown’s Impact at FDA Epstein Becker & Green, P.C.
Jun
1
2022
Unpacking Averages: Violations Found in Medical Device Warning Letters Epstein Becker & Green, P.C.
May
16
2019
FDA Declines to Ban Breast Implants, Will Require Full MDR Reporting by Manufacturers Epstein Becker & Green, P.C.
Jul
13
2022
FTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector Epstein Becker & Green, P.C.
Jun
18
2019
Employer Insights: Recreational Marijuana in Illinois Epstein Becker & Green, P.C.
Oct
13
2022
Four Years After Enactment – Clinical Laboratories Should Not Forget About EKRA Epstein Becker & Green, P.C.
Aug
22
2019
New York State Decriminalizes Possession of Marijuana Epstein Becker & Green, P.C.
Aug
13
2015
Telehealth / Remote Care 2.0: The Coming Disruption Epstein Becker & Green, P.C.
Jun
1
2023
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study Epstein Becker & Green, P.C.
Feb
27
2020
Antitrust Byte: FDA and FTC Join Forces to Promote Biosimilars Epstein Becker & Green, P.C.
Jun
13
2023
An “Overbroad” Noncompete – the NLRB Has Found Its First Target Epstein Becker & Green, P.C.
Mar
24
2020
FDA Eases Device Modification Rules to Expand Availability of Ventilators During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
22
2020
California Governor Mandates Supplemental Paid Sick Leave for Food Sector Workers at Companies with 500 or More Employees Epstein Becker & Green, P.C.
Jul
13
2020
Federal Courts Say They Will Decide Cases Against CBD Product Manufacturers When the Smoke Clears Epstein Becker & Green, P.C.
May
6
2024
Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies? Epstein Becker & Green, P.C.
Feb
12
2021
Bias in Healthcare Algorithms Epstein Becker & Green, P.C.
Jul
21
2017
Are Zero Tolerance Drug Testing Policies About to Go Up in Smoke? Epstein Becker & Green, P.C.
Nov
8
2017
FDA Issues Final Regulations Easing the Path for Direct-to-Consumer Genetic Testing Epstein Becker & Green, P.C.
Jun
29
2018
Recreational Marijuana in Massachusetts: What Should Employers Know? Epstein Becker & Green, P.C.
Oct
16
2018
New Draft Guidance on Adaptive Designs for Clinical Trials Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins